Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Bladder neck contracture: incidence, mechanisms, and therapeutic advances

Ren Y., Wu M., Jia L., Rui H.

Narrative Review on Scar, Chronic Inflammation, published in Ann Med Surg (Lond) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Ann Med Surg (Lond) (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41180741
PMCID
PMC12578012
DOI
10.1097/ms9.0000000000003930

Abstract (original English)

Bladder neck contracture (BNC) is a progressive narrowing of the bladder neck and adjacent posterior urethra, primarily caused by fibrotic tissue proliferation and scar formation. It commonly occurs following prostate surgery or radiotherapy. Its pathogenesis involves acute and chronic inflammatory responses triggered by surgical or radiation-induced injury, transdifferentiation of fibroblasts into myofibroblasts, and excessive extracellular matrix (ECM) deposition, mediated by the interplay of transforming growth factor beta (TGF-β)/Smad signaling and mechanotransduction feedback. Clinically, patients present with voiding difficulty, a weakened urinary stream, increased post-void residual volume, and urinary retention, which may be complicated by urinary tract infections, bladder stones, and renal impairment. Diagnosis is based on medical history, urodynamic studies, ultrasound, voiding cystourethrography(VCUG), and cystoscopic evaluation. Treatment follows a stepwise approach ranging from conservative management to endoscopic and then surgical interventions. First-line therapies include transurethral dilation or incision, often combined with local anti-scar agents and intermittent self-catheterization. Refractory or recurrent cases may require open or robot-assisted reconstructive surgery. Robot-assisted surgery, with its high-definition 3D visualization, multi-degree-of-free

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research